Skip to content

Application of dexmedetomidine combined with ketamine in children's difficult Intubation

Application of dexmedetomidine combined with ketamine in children's difficult Intubation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014686
Enrollment
Unknown
Registered
2018-01-29
Start date
2018-02-22
Completion date
Unknown
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

difficult Intubation

Interventions

dexmedetomidine and ketamine:Intravenous injection with dexmedetomidine before intubation
midazolam and fentanyl:Intravenous injection with midazolam and fentanyl before intubation

Sponsors

Shanghai Ninth People's Hospital, School Of Medicine, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 8 Years

Inclusion criteria

Inclusion criteria: (1) ASA I-II; (2) Aged from 2 to 8 years old; (3) Elective surgery for children under general anesthesia; (4) Children needs nasal fiber bronchoscopy with spontaneous breathing.

Exclusion criteria

Exclusion criteria: (1) Allergic to study drugs; (2) A history of cardiovascular disease,abnormal liver/kidney/coagulation/nervous system function; (3) Cardia arrhythmia; (4) Any congenital malformation disease; (5) difficult mask ventilation; (6) Children who refuse to participate in this study.

Design outcomes

Primary

MeasureTime frame
Intubation success rate for the first time;

Secondary

MeasureTime frame
Sedation score and BIS value before cricothyroid membrane puncture;Intubation score and intubation time;Hemodynamic changes and the incidence of serious complications during intubation;

Countries

China

Contacts

Public ContactLiu Jinxing

Shanghai Ninth People's Hospital, School Of Medicine, Shanghai Jiaotong University

liujinxing323@163.com+86 13817390501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026